Clinical effect, safety and mechanisms of BICOM 2000 system to asthma in children

A clinical study of the BICOM 2000 system in childhood asthma: 124 children with asthma and 150 with asthma and rhinitis, graded mild, moderate and severe against the national child asthma standard. Allergen detection and desensitisation were assessed alongside serum IL-4, total IgE and interferon gamma before and after treatment, with inhaled glucocorticoids as comparison.

Practitioner Library Membership Required

You must be a Practitioner Library member to access this content.

Join Now

Already a member? Log in here
author avatar
David Franklin
David Franklin is an advocate of Bioresonance therapy. He has seen how this form of treatment has helped his wife Sarah, who suffers from Addisons disease. David supplies Bicom Optima devices to therapists all over the world, and he also trains them on how to use the medical equipment effectively.